Tremor and Other Hyperkinetic Movements

metrics 2024

Pioneering research for transformative clinical practices.

Introduction

Tremor and Other Hyperkinetic Movements is a pioneering open-access journal published by UBIQUITY PRESS LTD, dedicated to advancing the understanding of hyperkinetic movement disorders, including tremors. Since its inception in 2011, the journal has provided a vital platform for researchers, professionals, and students within the fields of neurology and movement disorders to share innovative findings, case studies, and clinical trials. With its contributions spanning from 2012 to 2024, the journal emphasizes high-quality research and fosters collaboration within the medical community. Although it holds a Scopus rank of 156 in the field of Medicine, particularly Cardiology and Cardiovascular Medicine, its value extends beyond metrics, inviting interdisciplinary dialogue about the mechanisms, treatments, and implications of these complex disorders. By offering unrestricted access to its content, Tremor and Other Hyperkinetic Movements ensures that crucial knowledge reaches a global audience, thus enabling advancements in clinical practices and improved patient outcomes.

Metrics 2024

SCIMAGO Journal Rank-
Journal Impact Factor2.50
Journal Impact Factor (5 years)2.00
H-Index-
Journal IF Without Self2.50
Eigen Factor0.00
Normal Eigen Factor0.29
Influence0.64
Immediacy Index0.50
Cited Half Life5.60
Citing Half Life9.90
JCI0.57
Total Documents-
WOS Total Citations961
SCIMAGO Total Citations-
SCIMAGO SELF Citations-
Scopus Journal Rank-
Cites / Document (2 Years)-
Cites / Document (3 Years)-
Cites / Document (4 Years)-

Metrics History

Rank 2024

Scopus

Cardiology and Cardiovascular Medicine in Medicine
Rank #156/387
Percentile 59.69
Quartile Q2

IF (Web Of Science)

CLINICAL NEUROLOGY
Rank 127/277
Percentile 54.30
Quartile Q2

JCI (Web Of Science)

CLINICAL NEUROLOGY
Rank 181/278
Percentile 34.89
Quartile Q3

Quartile History

Similar Journals

Therapeutic Advances in Urology

Exploring Breakthroughs in Urological Therapies and Treatments
Publisher: SAGE PUBLICATIONS LTDISSN: 1756-2872Frequency: 1 issue/year

Therapeutic Advances in Urology is a distinguished, peer-reviewed journal published by SAGE Publications Ltd, dedicated to disseminating groundbreaking research and advancements in the field of urology. With an impressive impact factor and classified in the Q2 category for Urology as of 2023, this journal plays a critical role in advancing knowledge and clinical practices related to urological diseases and therapies. Since its establishment in 2009, the journal has transitioned to an Open Access format as of 2019, ensuring that vital research findings are freely available to researchers, healthcare professionals, and students worldwide. The journal is ranked #44 out of 120 in the Medicine - Urology category within Scopus, reflecting its commitment to high-quality, impactful scholarship. Whether you are seeking to keep abreast of the latest therapeutic innovations or contribute to the evolving discourse in urology, Therapeutic Advances in Urology is an essential resource for those passionate about improving patient outcomes and advancing clinical practices.

INTERNATIONAL JOURNAL OF HEMATOLOGY

Advancing the Science of Blood Health
Publisher: SPRINGER JAPAN KKISSN: 0925-5710Frequency: 12 issues/year

The INTERNATIONAL JOURNAL OF HEMATOLOGY, published by SPRINGER JAPAN KK, serves as a critical platform for advancing research in the field of hematology. With a prestigious history spanning over three decades from 1991 to 2024, this journal is recognized for its impactful contributions, evidenced by its Q2 category ranking in Hematology for 2023, and its notable position at rank #71 out of 137 in the Scopus Medicine Hematology category. Researchers and professionals within the hematology community benefit from the journal's rigorous peer-reviewed articles that cover a wide range of topics, including clinical studies, basic research, and novel therapeutic strategies. Though currently non-open access, it provides essential insights and findings to an audience passionate about the latest advancements in blood disorders and treatments. Situated in Japan, the journal not only showcases high-quality research but also fosters a global exchange of knowledge in hematology, making it a significant resource for scholars, practitioners, and students alike.

Movement Disorders Clinical Practice

Bridging research and practice for better patient care.
Publisher: WILEYISSN: 2330-1619Frequency: 8 issues/year

Movement Disorders Clinical Practice, published by WILEY, is an essential peer-reviewed journal dedicated to advancing the understanding and treatment of movement disorders from a clinical perspective. With an ISSN of 2330-1619, this journal serves as a vital resource for researchers, clinicians, and students engaged in neurology and clinical neuroscience. Since its inception in 2014, the journal has established itself within the medical community, currently positioned in the Q2 category for both Neurology and Neurology (Clinical), reflecting its influence and reputation. Although it does not offer open access, the journal is integral for disseminating high-quality research and clinical insights, thereby contributing significantly to improved patient care and outcomes in the field of movement disorders. Based in Hoboken, NJ, it continues to attract contributions from leading experts and aims to foster a deeper understanding and dialogue surrounding contemporary challenges and advancements in movement disorder treatment.

Intractable & Rare Diseases Research

Advancing Knowledge for the Uncommon.
Publisher: INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENTISSN: 2186-3644Frequency: 4 issues/year

Intractable & Rare Diseases Research is a pioneering journal dedicated to advancing the understanding and treatment of rare and intractable diseases. Published by INT RESEARCH & COOPERATION ASSOC BIO & SOCIO-SCIENCES ADVANCEMENT in Japan, this esteemed journal serves as a critical platform for researchers, clinicians, and healthcare professionals to share groundbreaking findings and developments in the field. With its established Scopus ranking of #238 out of 636 in the General Medicine category, placing it in the 62nd percentile, and its classification in the Q3 quartile for 2023, it is recognized as a significant contributor to the literature on rare diseases. Operating without an open-access model, the journal ensures high-quality content cultivated through rigorous peer-review processes. Through its scope spanning from 2012 to 2024, the journal aspires to bridge gaps in knowledge and foster collaboration among interdisciplinary researchers, ultimately aiming to improve patient outcomes and enhance public health concerning these challenging conditions.

NEUROMUSCULAR DISORDERS

Exploring the intersection of genetics and neurology.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0960-8966Frequency: 12 issues/year

NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.

ERJ Open Research

Transforming Respiratory Research into Global Knowledge
Publisher: EUROPEAN RESPIRATORY SOC JOURNALS LTDISSN: Frequency: 4 issues/year

ERJ Open Research is a distinguished Open Access journal dedicated to advancing the field of pulmonary and respiratory medicine, published by the European Respiratory Society Journals Ltd. Established in 2015, the journal proudly provides a platform for innovative research and comprehensive studies that address vital questions in respiratory health. With an impressive Q1 ranking in Scopus for Pulmonary and Respiratory Medicine and positioned in the top 73rd percentile among its peers, ERJ Open Research is a critical resource for researchers, clinicians, and students alike. The journal’s commitment to open access ensures that high-quality research is readily available to the global community, fostering collaboration and knowledge-sharing. Whether you are looking to publish groundbreaking findings or stay updated on the latest advancements in respiratory medicine, ERJ Open Research is the premier destination for impactful scholarly contributions.

CURRENT TREATMENT OPTIONS IN ONCOLOGY

Transforming Research into Real-World Oncology Solutions
Publisher: SPRINGERISSN: 1527-2729Frequency: 12 issues/year

CURRENT TREATMENT OPTIONS IN ONCOLOGY, published by Springer, is a premier academic journal dedicated to disseminating cutting-edge research and advancements in the field of oncology and pharmacology. With a commendable impact factor and ranked in the Q1 category in both oncology and pharmacology for 2023, this journal positions itself as a leading resource for researchers, healthcare professionals, and students alike, offering insightful reviews and original articles that critically evaluate treatment methodologies and clinical practices. Covering a wide scope of topics from early detection to innovative therapies, it fosters the translation of research findings into clinical applications. With its convergence years spanning from 2000 to 2024, CURRENT TREATMENT OPTIONS IN ONCOLOGY continues to be at the forefront of oncological research, providing a platform for scholars to explore the latest therapeutic options and improve patient outcomes. Highly regarded in the academic community, this journal is essential for anyone looking to stay informed about the dynamic landscape of cancer treatment.

Journal of Neuromuscular Diseases

Exploring the frontiers of neurology and muscle disorders.
Publisher: IOS PRESSISSN: 2214-3599Frequency: 1 issue/year

Journal of Neuromuscular Diseases, published by IOS PRESS, is a leading platform dedicated to advancing the field of neurology and neuromuscular research. With a focus on delivering high-quality, peer-reviewed content, this journal aims to foster knowledge sharing and collaboration among researchers, clinicians, and healthcare professionals dealing with neuromuscular disorders. The journal boasts a commendable impact factor within its respective categories, achieving Q2 rankings in both Neurology and Clinical Neurology as of 2023. Spanning from its inception in 2014 to the anticipated convergence in 2024, it is recognized for its contributions to critical discussions in the field, evidenced by its rankings of #145 out of 400 in clinical neurology and #75 out of 192 in neuroscience. As an open access journal, it facilitates wider accessibility of research findings, catering to an audience eager for innovative approaches and developments. Set against the backdrop of the vibrant academic scene in the Netherlands, the Journal of Neuromuscular Diseases serves as an essential resource for driving forward the boundaries of knowledge in neuromuscular-related conditions.

Neurology and Therapy

Advancing Neurological Health Through Open Access Research
Publisher: SPRINGER LONDON LTDISSN: 2193-8253Frequency: 2 issues/year

Neurology and Therapy, published by SPRINGER LONDON LTD, stands as a pivotal platform for researchers and practitioners in the field of neurology and its therapeutic applications. This Open Access journal, active since 2012, facilitates the dissemination of innovative studies and cutting-edge findings aimed at improving neurological health. With an impressive ranking in the 2023 Scopus Rankings, where it holds a Q2 category in Neurology and a Q1 category in Clinical Neurology, it underscores its prominence in advancing neurological research. The journal's intriguing scope encompasses a wide-ranging exploration of neurological disorders, treatment methodologies, and healthcare strategies, making it a valuable resource for those vested in enhancing patient outcomes. With an appealing average impact factor, readers are encouraged to dive into the latest advancements and engage with the scholarly discussions that are shaping the future of neurology.

STEREOTACTIC AND FUNCTIONAL NEUROSURGERY

Uncovering Breakthroughs in Functional Neurosurgery
Publisher: KARGERISSN: 1011-6125Frequency: 6 issues/year

STERREOTACTIC AND FUNCTIONAL NEUROSURGERY, published by KARGER, is a distinguished journal focusing on the evolving fields of neurosurgery and functional neurology. With its ISSN of 1011-6125 and E-ISSN of 1423-0372, this journal has been at the forefront of publishing innovative research since its inception in 1938, securing a prominent position within the scientific community through its commitment to high-quality peer-reviewed articles. As of 2023, it ranks in the Q3 quartile for Clinical Neurology and Q2 for Surgery, reflecting its impactful contributions and relevance to current medical practice. Researchers and practitioners alike will benefit from the journal’s exploration of novel techniques, therapeutic advancements, and clinical outcomes in stereotactic and functional neurosurgery, making it an invaluable resource for those aiming to stay abreast of the latest developments in this dynamic field. Although it does not currently offer open access, readers can access its content via institutional subscriptions, ensuring widespread dissemination of critical research findings aimed at improving patient care and advancing surgical methodologies.